Pharmacokinetics, safety, and efficacy of glecaprevir/pibrentasvir in children with chronic hepatitis C virus: part 2 of the DORA study
Keyword(s):
Keyword(s):
2019 ◽
Vol 2
(7)
◽
pp. 03-07
◽
2015 ◽
Vol 62
◽
pp. S284-S285
◽
2021 ◽
Vol 11
(2)
◽
pp. 199-207
2010 ◽
Vol 105
◽
pp. S114